TAT-MeCP2 protein variants rescue disease phenotypes in human and mouse models of Rett syndrome-Reference-Cited by-同舟云学术

TAT-MeCP2 protein variants rescue disease phenotypes in human and mouse models of Rett syndrome

Published:2022-06 Issue: Volume:209 Page:972-983
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Steinkellner Hannes,Kempaiah Prakasha,Beribisky Alexander V.,Pferschy Sandra,Etzler Julia,Huber Anna,Sarne Victoria,Neuhaus Winfried,Kuttke Mario,Bauer Jan,Arunachalam Jayamuruga P.,Christodoulou John,Dressel Ralf,Mildner Alexander,Prinz Marco,Laccone Franco

Funder

Royal Children's Hospital Foundation

State Government of Victoria

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference72 articles.

1. On a unusual brain atrophy syndrome in hyperammonemia in childhood;Rett;Wien Med Wochenschr,1966

2. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2;Amir;Nat. Genet.,1999

3. Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation;Nagarajan;Epigenetics,2006

4. Evolving role of MeCP2 in Rett syndrome and autism;Lasalle;Epigenomics,2009

5. MeCP2, a key contributor to neurological disease, activates and represses transcription;Chahrour;Science,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MeCP2 is a naturally supercharged protein with cell membrane transduction capabilities;Protein Science;2024-09-14

2. Epigenetics in rare neurological diseases;Frontiers in Cell and Developmental Biology;2024-07-23

3. Generation and Characterization of a Human Neuronal In Vitro Model for Rett Syndrome Using a Direct Reprogramming Method;Stem Cells and Development;2024-03-01

4. Dose-Dependent Nuclear Delivery and Transcriptional Repression with a Cell-Penetrant MeCP2;ACS Central Science;2023-02-03

5. Dose-dependent nuclear delivery and transcriptional repression with a cell-penetrant MeCP2;2022-06-04